期刊
CLINICAL ENDOCRINOLOGY
卷 73, 期 6, 页码 715-722出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1365-2265.2010.03870.x
关键词
-
资金
- Medical Research Council (MRC), UK [G9825289/2004]
- Medical Research Council [G84/6423, G9825289] Funding Source: researchfish
- MRC [G84/6423, G9825289] Funding Source: UKRI
P>Background Inactivating mutations of the calcium-sensing receptor (CaSR), a G-protein-coupled receptor with extracellular (ECD), transmembrane (TMD) and intracellular (ICD) domains, cause familial hypocalciuric hypercalcaemia, neonatal severe primary hyperparathyroidism and occasionally primary hyperparathyroidism in adults. Objective To investigate a patient with typical symptomatic primary hyperparathyroidism for CaSR abnormalities. Patient and design A 51-year-old woman with primary hyperparathyroidism was investigated for CaSR abnormalities as her severe hypercalcaemia (3 center dot 75 mm) persisted after the removal of two large parathyroid adenomas and she was the daughter of normocalcaemic consanguineous parents. Following informed consent, CASR mutational analysis was undertaken using leucocyte DNA. Wild-type and mutant CaSR constructs were expressed in human embryonic kidney (HEK) 293 cells and assessed by measuring their intracellular calcium responses to changes in extracellular calcium. Clinical data were pooled with previous studies to search for genotype-phenotype correlations. Results The proband was homozygous for a Pro339Thr CaSR missense mutation, located in the ECD, and her normocalcaemic relatives were heterozygous. The mutant Thr339 CaSR had a rightward shift in its dose-response curve with a significantly higher EC50 = 3 center dot 18 mm +/- 0 center dot 19 compared to the wild-type EC50 = 2 center dot 16 mm +/- 0 center dot 1 (P < 0 center dot 01), consistent with a loss-of-function mutation. An analysis of CaSR mutations in patients with primary hyperparathyroidism revealed that those of the ECD were associated with a significantly greater hypercalcaemia that was less likely to be corrected after removal of the parathyroid tumours. Conclusions A CaSR missense mutation causing a loss-of-receptor-function can cause symptomatic primary hyperparathyroidism in adulthood.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据